Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Immunological Medicines for Poultry

Immunological veterinary medicinal products, including vaccines, are authorised for poultry.

Search results 1 to 25 from a total of 128

Name De­scrip­tion Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date An­i­mal Further Information

Vectormune ND

Marek'sche Krankheit, Newcastle-Krankheit

CEVA-Phylaxia Co. Ltd., Ungarn

EU/2/15/188 08.09.2015 Huhn

EPAR: Vectormune ND

Vectormune FP ILT + AE

Hühnerpocken, Aviäre Infektiöse Laryngotracheitis, Aviäre Enzephalomyelitis

CEVA-Phylaxia Co. Ltd., Ungarn

EU/2/20/250 24.04.2020 Huhn

Vectormune FP ILT

Hühnerpocken, Infektiöse Laryngotracheitis

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/20/266 09.12.2020 Huhn

Vaxxitek HVT + IBD

Infektiöse Bursitis,
Marek'sche Krankheit

Boehringer Ingelheim Vetmedica GmbH

EU/2/02/032/001 13.08.2002 Huhn

EPAR: Vaxxitek HVT + IBD

Ultifend ND IBD

Newcastle-Krankheit, Infektiöse Bursitis, Marek'sche Krankheit

Ceva-Phylaxia Co. Ltd., Ungarn

EU/2/21/272 20.04.2021 Huhn

Trituren

Newcastle Disease,
Paramyxovirose der Pute,
Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

38a/92 27.12.1994 Pute

Terivac

Infektiöse Rhinotracheitis

Boehringer Ingelheim Vetmedica GmbH

106a/90 18.11.1998 Pute

RP Vacc

Paramyxovirose der Taube, Rotavirus-Infektion der Taube

Pharmagal Bio, spol.s.r.o., Slowakei

PEI.V.12101.01.1 06.12.2021 Taube

PRIMUN SALMONELLA T

Salmonellen-Infektion

Laboratorios Calier S.A., Spanien

PEI.V.12106.01.1 13.07.2022 Huhn

PRIMUN SALMONELLA E

Salmonellen-Infektion

Laboratorios Calier S.A., Spanien

PEI.V.11784.01.1 07.09.2015 Huhn

PRIMUN NEWCASTLE HB1

Newcastle-Krankheit

Laboratorios Calier S.A., Spanien

PEI.V.11870.01.1 19.07.2017 Huhn

PRIMUN NEWCASTLE C30

Newcastle-Krankheit

Laboratorios Calier S.A., Spanien

PEI.V.11935.01.1 29.05.2018 Huhn

PRIMUN IB-ND DUO

Newcastle-Krankheit, Infektiöse Bronchitis

Laboratorios Calier S.A., Spanien

PEI.V.11966.01.1 28.01.2019 Huhn

PRIMUN GUMBORO W2512

Infektiöse Bursitis

Laboratorios Calier S.A., Spanien

PEI.V.12107.01.1 10.02.2022 Huhn

PRIMUN GUMBORO

Infektiöse Bursitis

Laboratorios Calier S.A., Spanien

PEI.V.11852.01.1 01.02.2019 Huhn

PRIMUN BRONCHITIS H120

Infektiöse Bronchitis

Laboratorios Calier S.A., Spanien

PEI.V.11967.01.1 15.04.2019 Huhn

Prevexxion RN+HVT+IBD

Marek‘sche Krankheit, Infektiöse Bursitis

Boehringer Ingelheim Vetmedica GmbH

EU/2/20/255 20.07.2020 Huhn

EPAR: Prevexxion RN+HVT-IBD

PREVEXXION RN+HVT

Marek'sche Krankheit

Boehringer Ingelheim Vetmedica GmbH

EU/2/23/302 26.10.2023 Huhn

EPAR: PREVEXXION RN+HVT

Prevexxion RN

Marek‘sche Krankheit

Boehringer Ingelheim Vetmedica GmbH

EU/2/20/254 20.07.2020 Huhn

EPAR: Prevexxion RN

Poulvac TRT

Infektiöse Rhinotracheitis

Zoetis Deutschland GmbH

PEI.V.01721.01.1 05.12.2000 Pute

Poulvac Procerta HVT-IBD

Marek'sche Krankheit, Infektiöse Bursitis

Zoetis Belgium

EU/2/23/300 27.10.2023 Huhn

EPAR: Poulvac Procerta HVT-IBD

Poulvac ND Hitchner B1

Newcastle-Krankheit

Zoetis Deutschland GmbH

PEI.V.00375.01.1 22.04.1999 Huhn

Poulvac MG

Mykoplasmen-Infektion

Zoetis Deutschland GmbH

80a/88 26.02.2004 Huhn

Poulvac Marek CVI + HVT

Marek'sche Krankheit

Zoetis Deutschland GmbH

PEI.V.01271.01.1 31.05.2000 Huhn

Poulvac IB QX

Infektiöse Bronchitis

Zoetis Deutschland GmbH

PEI.V.11668.01.1 12.04.2013 Huhn

Disclaimer

The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 518 in BAnz AT 26.06.2024 B7.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 26.06.2024